2025.   Effectiveness and safety of Lanadelumab according to disease activity: pooled analysis of EMPOWER/ENABLE . Revista Alergia México. 72, 3 (Sep. 2025), 221–222. DOI:https://doi.org/10.29262/ram.v72i3.1505.